FIELD: organic chemistry, steroids, medicine.
SUBSTANCE: invention relates to steroid compounds or their salt corresponding to the general formula (I): A - (B)bo - C - N(O)2 (I) wherein bo = 1; A means R- wherein R is a radical of steroid medicinal substance; C1 and C2 represent bivalent radicals. Precursor of radical B1 must correspond to conditions of pharmacological tests and they content is disclosed in the description. Compounds of the formula (I) are useful in treatment of inflammatory diseases, asthma and hepatic disorders.
EFFECT: valuable medicinal properties of compound.
10 cl, 6 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
NEW MEDICINAL AGENTS | 2000 |
|
RU2237657C2 |
NEW MEDICINAL AGENTS | 2000 |
|
RU2237057C2 |
COMPOUNDS, THEIR USING FOR TREATMENT OF DISORDER IN PORTAL AND HEPATIC VENOUS CIRCULATION | 2003 |
|
RU2299886C2 |
MEDICINAL SUBSTANCES AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF FOR USING IN CASES OF OXIDATIVE STRESS | 2000 |
|
RU2264383C2 |
BLOOD DEPOT AGENTS FOR MAKING NUCLEAR MAGNETIC RESONANCE DIAGNOSIS | 1999 |
|
RU2250765C2 |
NEUROACTIVE STEROIDS, PHARMACEUTICAL PREPARATION, METHOD OF TREATMENT AND PROPHYLAXIS OF DIFFERENT DISORDERS, METHOD OF SLEEP INDUCTION AND METHOD OF ANESTHESIA INDUCTION WITH THEIR USING, METHOD OF MODULATION OF COMPLEX RECEPTOR GABAA-CHLORIDE IONOPHORE | 1996 |
|
RU2194712C2 |
METHOD OF PRODUCING GAMMA AMIDES OF GLUTAMIC ACID | 1999 |
|
RU2395490C2 |
STEROID COMPOUNDS (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OF PATIENTS WITH NERVOUS DISORDERS (VARIANTS) AND METHOD OF ANESTHESIA INDUCTION IN ANIMAL | 1995 |
|
RU2176248C2 |
NEW STEROID COMPOUNDS SHOWING HIGHER WATER SOLUBILITY AND METABOLISM RESISTANCE, AND METHODS FOR PREPARING THEM | 2007 |
|
RU2458065C2 |
AGENTS FOR INHIBITING ENZYME TYROSYL-DNA-PHOSPHODIESTERASE 1 BASED ON BILE ACIDS | 2018 |
|
RU2689335C1 |
Authors
Dates
2004-11-20—Published
2000-04-11—Filed